Cost-effectiveness of the implantable cardioverter defibrillator.

Cardiac electrophysiology review

Volumn 7, Issue 4, 2003, Pages 479-482

  Hlatky, Mark A ^a   Sanders, Gillian D ^a   Owens, Douglas K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DEFIBRILLATOR; ECONOMICS; HUMAN; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL RATE; UNITED STATES;

COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; HUMANS; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL RATE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 4143107791     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEPR.0000023153.81976.3a     Document Type: Article

References (0)